Clinical Trials Directory

Trials / Sponsors / Laboratorios Andromaco S.A.

Laboratorios Andromaco S.A.

Industry · 19 registered clinical trials.

StatusTrialPhaseStarted
CompletedBioavailability of Eszopiclone 3.0 mg With Regards to Reference Product
Bioequivalence
Phase 12022-04-11
CompletedBioavailability of Estradiol Valerate and Dienogest 2 mg/2 mg With Regards to Reference Product
Bioequivalence
Phase 12022-03-12
CompletedBioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Prod
Therapeutic Equivalency
Phase 12022-02-26
CompletedBioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product
Bioequivalence
Phase 12022-02-14
CompletedBioavailability of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to Reference Product
Bioequivalence
Phase 12021-11-04
CompletedBioavailability of Oseltamivir Phosphate 75 mg With Regards to Reference Product
Bioequivalence
Phase 12021-10-08
CompletedBioavailability of Duloxetine 60 mg With Regards to Reference Product in Feeding Conditions
Bioequivalence
Phase 12021-02-27
CompletedBioavailability of Duloxetine 60 mg With Regards to Reference Product in Fasting Conditions
Bioequivalence
Phase 12021-01-23
CompletedBioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product
Bioequivalence
Phase 12021-01-16
CompletedBioavailability of Levonorgestrel/Ethinyl Estradiol Tablets 0.1 mg/0.02 mg With Regards to Reference Product
Bioequivalence
Phase 12020-11-21
CompletedBioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Prod
Bioequivalence
Phase 12020-10-24
CompletedBioavailability of Clotiazepam 5 mg With Regards to Reference Product
Bioequivalence
Phase 12020-03-11
CompletedBioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product
Bioequivalence
Phase 12020-01-11
CompletedBioavailability of Dienogest 2.0 mg With Regards to Reference Product
Bioequivalence
Phase 12019-12-07
CompletedBioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product
Bioequivalence
Phase 12019-11-09
CompletedPharmacokinetics of a Novel Vaginal Delivery System for Testosterone and Dehydroepiandrosterone (DHEA)
Pharmacokinetics, Hormone Deficiency
Phase 12015-11-20
CompletedAssess the Effect of Dehydroepiandrosterone (DHEA) or Other Androgenic Agents Over Markers of Ovarian Reserve
Healthy Women, Infertility, Female
Phase 12014-07-15
CompletedAssessment of a Vaginal Ring With Meloxicam in the Treatment of Dysmenorrhea
Dysmenorrhea
Phase 2 / Phase 32014-06-27
CompletedAssessment of a Vaginal Ring With Meloxicam on Ovarian Cycle in Fertile Women
Contraception, Bleeding Pattern
Phase 12013-01-15